XBT Experiments
XBT (Xeno Biotechnologies) is a privately owned corporation, founded shortly after the first confirmed discovery of a complex alien organism on the remote Kerguelen Islands in 2012. By 2019, its researchers had fully sequenced the creature’s genome—a breakthrough hailed as one of the century’s greatest scientific milestones. Two years later, XBT secretly began splicing alien DNA into human and animal subjects.

Officially, the company insists its mission is to “advance human welfare.” But leaked files tell a different story: the creation of hybrid organisms—classified internally as Products—engineered not for medicine, but for sale on the global black market as living weapons. One such report details the catastrophic escape of Product 02, an incident that left hundreds dead and raised chilling questions about how many more are being bred in the shadows.